is there a shortage of compounded semaglutide FDA says that the GLP-1 over FDA crackdown on off-brand Ozempic

References 1.Roach P.J., Depaoli-Roach A.A., Hurley T.D., Tagliabracci V.S

Cell culture Primary human umbilical vein endothelial cells (HUVECs) were cultured in Endothelial Cell Medium (ECM) supplemented with 5% fetal bovine serum (FBS) and 1% endothelial cell growth supplement (ECGS)

Up to $2.4B in milestones In addition, Metsera shareholders will receive a non-transferable contingent value right (CVR) entitling them to potential additional payments of up to $22.50 per share cashadding up to $2.4 billion to the value of the dealtied to three specific clinical and regulatory milestones: $5 per share upon the start of Phase III clinical trials for Metseras MET-097i+MET-233i combination $7 per share upon FDA approval of Metseras monthly MET-097i monotherapy $10.50 per share upon FDA approval of Metseras monthly MET-097i+MET-233i combination The acquisition transaction is expected to close in the fourth quarter, subject to satisfying customary closing conditions, including receipt of required regulatory approvals and approval by Metseras shareholders

In zon korte tijd heb ik al veel bereikt

& Perez-Cruz, C